AIDP, based in City of Industry, CA, will distribute an ingredient called BIOHM FX, developed by BIOHM Health LLc, which is based in Cleveland, OH. The ingredient is a unique blend of active probiotic cultures, beneficial fungi and digestive enzymes.
The ingredient was developed by Dr Mahmoud Ghannoum, PhD, who is the director of the Center for Medical Mycology at Case Western Reserve University, also in Cleveland. His research has helped to uncover the links between microbial and fungal communities in the gut.
In a recent paper published in an Italian journal title Digestive and Liver Disease, Ghannoum found that, “[P]atients with Crohn's disease (CD) tend to have much higher levels of the fungus Candida tropicalis compared to their healthy family members, as well as two bacteria, Escherichia coli and Serratia marcescens. Furthermore, we showed that these three organisms worked together to form robust biofilms capable of exacerbating intestinal inflammation.”
Ghannoum’s new ingredient is focused on inhibiting the development of these sorts of biofilms in the gut. It is said to maintain the balance of bacteria and fungi in the gut, all while breaking down digestive biofilms. BIOHM is said to protect against bad bacteria and bad fungi that upset the balance of your gut. The company claims it is the probiotic proven to support the breakdown of digestive biofilm.
“As AIDP continues to build its digestive health portfolio, we are constantly looking for innovative ingredients that provide unique benefits within their categories,” says Mark Thurston, president of AIDP. “BIOHM’s probiotic formulated ingredient provides a new approach to digestive health. While most probiotics help increase bacteria in the gut, the research supporting this new ingredient suggests BIOHM FX may help break apart stubborn biofilms. Not only this, but the BIOHM probiotic also contains enzymes, bacteria AND fungi. This is a truly unique ingredient.”
